WO2011027719A1 - ラクトバチルス属乳酸菌の増殖促進剤及び/又は生残性向上剤 - Google Patents
ラクトバチルス属乳酸菌の増殖促進剤及び/又は生残性向上剤 Download PDFInfo
- Publication number
- WO2011027719A1 WO2011027719A1 PCT/JP2010/064569 JP2010064569W WO2011027719A1 WO 2011027719 A1 WO2011027719 A1 WO 2011027719A1 JP 2010064569 W JP2010064569 W JP 2010064569W WO 2011027719 A1 WO2011027719 A1 WO 2011027719A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lactic acid
- acid bacteria
- lactobacillus
- survival
- growth
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 248
- 241000894006 Bacteria Species 0.000 title claims abstract description 142
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 124
- 239000004310 lactic acid Substances 0.000 title claims abstract description 124
- 241000186660 Lactobacillus Species 0.000 title claims abstract description 51
- 229940039696 lactobacillus Drugs 0.000 title claims abstract description 50
- 239000003795 chemical substances by application Substances 0.000 title abstract description 7
- 239000000203 mixture Substances 0.000 claims abstract description 45
- 235000013305 food Nutrition 0.000 claims abstract description 43
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- 230000004083 survival effect Effects 0.000 claims description 73
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 35
- 239000007952 growth promoter Substances 0.000 claims description 32
- 230000001737 promoting effect Effects 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 20
- 239000000796 flavoring agent Substances 0.000 abstract description 14
- 235000019634 flavors Nutrition 0.000 abstract description 14
- 230000000704 physical effect Effects 0.000 abstract description 12
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 230000035755 proliferation Effects 0.000 abstract description 2
- 239000004129 EU approved improving agent Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 108010083502 kappa-caseinoglycopeptide Proteins 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 235000013618 yogurt Nutrition 0.000 description 19
- 239000000047 product Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- 239000006041 probiotic Substances 0.000 description 10
- 235000018291 probiotics Nutrition 0.000 description 10
- 108010076119 Caseins Proteins 0.000 description 8
- 102000011632 Caseins Human genes 0.000 description 8
- 230000000529 probiotic effect Effects 0.000 description 7
- 235000015140 cultured milk Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000005018 casein Substances 0.000 description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
- 235000021240 caseins Nutrition 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 235000021246 κ-casein Nutrition 0.000 description 4
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 229940123973 Oxygen scavenger Drugs 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000005862 Whey Substances 0.000 description 3
- 102000007544 Whey Proteins Human genes 0.000 description 3
- 108010046377 Whey Proteins Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000021239 milk protein Nutrition 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 2
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- -1 physical properties Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 108010058314 rennet Proteins 0.000 description 2
- 229940108461 rennet Drugs 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108700029181 Bacteria lipase activator Proteins 0.000 description 1
- 101800001415 Bri23 peptide Proteins 0.000 description 1
- 101800000655 C-terminal peptide Proteins 0.000 description 1
- 102400000107 C-terminal peptide Human genes 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108090000746 Chymosin Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000015155 buttermilk Nutrition 0.000 description 1
- 229940080701 chymosin Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 108010028463 kappa-casein glycomacropeptide Proteins 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
- FRASJONUBLZVQX-UHFFFAOYSA-N naphthoquinone group Chemical group C1(C=CC(C2=CC=CC=C12)=O)=O FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Definitions
- the present invention relates to a growth promoter and / or survival improver for Lactobacillus lactic acid bacteria, which contains a ⁇ -caseinoglyco macropeptide-containing substance as an active ingredient.
- lactic acid bacteria Useful microorganisms that can have beneficial effects on the host, such as improving the bacterial flora in the gastrointestinal tract, are called probiotics and are attracting attention.
- One such useful microorganism is lactic acid bacteria.
- lactic acid bacteria Recently, research on functionality of lactic acid bacteria has become active, and development of products incorporating new functionality using the lactic acid bacteria has also been progressing. Examples of such lactic acid bacteria include lactic acid bacteria belonging to the genus Lactobacillus.
- Fermented foods typified by fermented milk have a low pH environment and are often not suitable for the growth and survival of lactic acid bacteria. Promoting the growth of lactic acid bacteria in food or improving the survival is a great contribution to preventive medicine when the lactic acid bacteria have the functionality of probiotics as described above.
- Japanese Patent No. 3447358 includes a specific amount of lipid obtained by subjecting milk or a milk material (eg, buttersarum, buttermilk) to a specific treatment as a “lactic acid bacteria survival improver”. What to do is disclosed. Specifically, it is disclosed that this improver is added to a medium of lactic acid bacteria.
- Japanese Patent Application Laid-Open No. 2007-097447 discloses a bifidobacteria characterized by using a culture, a solvent extract and / or a treated product of a propionic acid bacterium and / or a compound-producing bacterium having a naphthoquinone ring.
- the survival improvement method of this is disclosed.
- propionic acid bacteria produce a growth promoting substance of bifidobacteria.
- ⁇ -caseinoglyco macropeptide has an effect of promoting the growth of bifidobacteria, but its mechanism of action has not yet been elucidated. Furthermore, as far as the present inventors know, it has not been known at all that ⁇ -caseinoglyco macropeptide has an effect of promoting the growth of lactic acid bacteria and an effect of improving the survival.
- the present inventors have recently promoted the growth of the lactic acid bacteria contained in the food composition without affecting the flavor and physical properties of the food composition containing the Lactobacillus lactic acid bacteria, and the survival properties thereof.
- the method to improve the effect was examined experimentally.
- ⁇ -caseinoglyco macropeptide which is a milk-derived material, without affecting the flavor and physical properties of the food composition containing Lactobacillus lactic acid bacteria, promote the growth of the lactic acid bacteria, And succeeded in improving the survival.
- the sustainability of the effect is high and excellent, and it was found that the quality can be maintained even during storage of the food composition.
- the present invention is based on these findings.
- the object is to provide a growth promoter and / or survival improver for Lactobacillus lactic acid bacteria that is excellent in sustainability and can contribute to quality maintenance during food storage.
- a growth promoter and / or survival improver for Lactobacillus lactic acid bacteria comprising ⁇ -caseinoglyco macropeptide as an active ingredient
- [4] The Lactobacillus lactic acid bacteria growth promoter and / or survival improver according to any one of [1] to [3] is added to the Lactobacillus lactic acid bacteria-containing composition.
- a method for promoting growth and / or improving survival of Lactobacillus lactic acid bacteria in a Lactobacillus lactic acid bacteria-containing composition [5] Before the fermentation of the lactic acid bacteria-containing composition, the lactic acid bacteria growth promoter and / or survival improver is added to the lactic acid bacteria-containing composition, [4] The method described in [6] A food composition comprising the Lactobacillus lactic acid bacteria growth promoter and / or survival improver according to any one of [1] to [3], and Lactobacillus lactic acid bacteria, [7] Use of ⁇ -caseinoglyco macropeptide for promoting growth and / or improving survival of Lactobacillus lactic acid bacteria in a composition containing Lactobacillus lactic acid bacteria.
- the composition containing Lactobacillus lactic acid bacteria such as food and food composition can be obtained by using ⁇ -caseinoglyco macropeptide.
- the growth of Lactobacillus lactic acid bacteria can be promoted and / or the survival can be improved.
- the growth of Lactobacillus lactic acid bacteria can be promoted and / or the survival can be improved.
- the growth of Lactobacillus genus lactic acid bacteria is promoted and / or survivability.
- the growth of Lactobacillus lactic acid bacteria can be promoted and / or the survival can be improved.
- the use of ⁇ -caseinoglyco macropeptide promotes the growth of the lactic acid bacteria without affecting the flavor and physical properties of foods and food compositions containing Lactobacillus lactic acid bacteria. / Or survival can be improved.
- 6 is a graph showing the survival rate of the number of bacteria of Lactobacillus gasseri OLL2716 strain (number of viable cells after storage days / number of viable cells at the start of storage (%)) in Experimental Example 1.
- 6 is a graph showing the survival rate of the number of bacteria of Lactobacillus gasseri OLL2959 strain in Experimental Example 2 (number of viable cells after storage days / number of viable cells at the start of storage (%)).
- 10 is a graph showing the number of bacteria (cfu / g) of Lactobacillus gasseri OLL2716 strain in Experimental Example 3.
- Lactic acid bacteria growth promoter and / or survival improver contains ⁇ -caseinoglyco macropeptide as an active ingredient. That is, the present invention promotes the growth of probiotic bacteria such as Lactobacillus lactic acid bacteria contained in yogurt and / or improves survival by using ⁇ -caseinoglyco macropeptide.
- probiotic bacteria such as Lactobacillus lactic acid bacteria contained in yogurt
- lactic acid bacterium growth promoter and / or survival enhancer refers to a lactic acid bacterium growth promoter, a lactic acid bacterium survival promoter, in addition to a drug that has both the performance of lactic acid bacteria growth promotion and survival improvement.
- lactic acid bacteria growth promoter and / or survival improver is an agent for promoting the growth and survival of lactic acid bacteria, or for promoting the growth and survival of lactic acid bacteria. It can be paraphrased as an additive for promoting the growth of lactic acid bacteria and improving survival.
- proliferation promotion of lactic acid bacteria means that when the lactic acid bacteria are in an environment suitable for the growth or maintenance of the lactic acid bacteria, the lactic acid bacteria act on the lactic acid bacteria to promote the growth of the lactic acid bacteria, thereby increasing the number of bacteria. Say that. In the present invention, preferably, it means that growth of lactic acid bacteria is promoted in a composition containing lactic acid bacteria under a predetermined storage environment.
- “improvement of survival” of lactic acid bacteria means that the number of lactic acid bacteria remaining alive by acting on lactic acid bacteria to suppress the death of lactic acid bacteria when in an environment suitable for the growth or maintenance of lactic acid bacteria. Say to maintain and improve.
- the number of surviving lactic acid bacteria is improved under the predetermined storage environment.
- ⁇ -caseinoglyco macropeptide is a fragment of ⁇ -casein, which is one of milk proteins, and is a C-terminal peptide containing a glycopeptide of ⁇ -casein.
- the ⁇ -caseinoglyco macropeptide is usually part of the casein micelle and is located at the outer edge of the micelle.
- the ⁇ -caseinoglyco macropeptide is usually available in the form of a ⁇ -caseinoglyco macropeptide-containing product.
- the ⁇ -caseinoglyco macropeptide-containing product can be prepared by separation by various methods. For example, it can be prepared by taking chymosin into milk protein.
- rennet, pepsin, or both can act on acid casein for curdling to form a rennet casein card, and can be prepared by utilizing whey produced at that time.
- the whey contains calcium phosphate, and the pH and temperature are adjusted (for example, the pH is adjusted to 8 to 9, and the temperature is adjusted to 50 to 60 ° C.) to precipitate and remove the calcium phosphate.
- the supernatant obtained in this way is adjusted to return to the neutral region, and after concentration and desalting with a reverse osmosis membrane, it can be prepared by spray drying or the like, if necessary.
- ⁇ -caseinoglyco macropeptide may be used if it is commercially available.
- the Lactobacillus lactic acid bacteria growth promoter and / or survival improver of the present invention includes the above-mentioned ⁇ -caseinoglyco macropeptide-containing product or a treated fraction as it is or diluted with a solvent. It is obtained as an insoluble fraction and can be used as it is.
- a solvent water or a commonly used solvent, for example, alcohols, hydrocarbons, organic acids, organic bases, inorganic acids, inorganic bases, supercritical fluids and the like can be used alone or in combination.
- Lactobacillus lactic acid bacteria growth promoter and / or survival improver of the present invention includes the above-mentioned ⁇ -caseinoglyco macropeptide itself or a processed product thereof, such as water, protein, carbohydrate, lipid, vitamin. It is also possible to obtain a combination of food compositions such as foods, minerals, organic acids, organic bases, fruit juices and flavors.
- the growth promoter and / or survival improver of lactic acid bacteria of the present invention is preferably 0.05 to 0.6% by weight, more preferably 0.1% in terms of the concentration of ⁇ -caseinoglyco macropeptide. It can be added to the lactic acid bacterium-containing composition so as to contain ⁇ 0.4 wt%, more preferably 0.2 ⁇ 0.3 wt%. At this time, the lactic acid bacterium-containing composition preferably contains Lactobacillus lactic acid bacteria, preferably 10 5 CFU / g or more, more preferably in the range of 10 6 to 10 9 CFU / g, and still more preferably 10 7 to 10 8 CFU. / G.
- the growth promoter and / or survival improver of Lactobacillus lactic acid bacteria promotes the growth and / or survival of the lactic acid bacteria in a low pH environment. It was able to demonstrate the function to improve the.
- Foods and food compositions containing lactic acid bacteria, such as fermented milk, are generally in a low pH environment and are often not suitable for the growth and / or survival of lactic acid bacteria.
- the growth promoter and / or survival improver of the present invention can exhibit functions of promoting the growth of lactic acid bacteria and / or improving the survival even in a low pH environment
- the lactic acid bacteria represented by fermented milk and the like It is useful in promoting the growth of lactic acid bacteria and / or improving the survival in foods and food compositions containing sucrose.
- the lactic acid bacteria growth promoter and / or survival improver of the present invention is more effective in a low pH environment that is differentiated from the prior art in consideration of the pH of foods and food compositions containing lactic acid bacteria. Can demonstrate its function.
- the low pH environment is preferably 2.5 to 6.5, more preferably 3.0 to 5.5, still more preferably 3.5 to 5.0, and most preferably pH.
- the pH is 3.8 to 4.8.
- the Lactobacillus lactic acid bacteria growth promoter and / or survival improver according to the present invention is particularly applied to Lactobacillus gasseri species whose excellent efficacy is being elucidated as Lactobacillus lactic acid bacteria. Is preferred.
- the Lactobacillus gasseri species are, for example, Lactobacillus gasseri OLL2716 (Lactobacillus gasseri OLL2716: FERM BP-6999) strain, Lactobacillus gasseri OLL2959 strain (Lactobacillus gasseri OLL2959: N).
- the effects of the lactic acid bacteria growth promoter and / or survival improver of the present invention have been experimentally confirmed in these strains.
- Lactobacillus gasseri OLL2716 strain is deposited at the National Institute of Advanced Industrial Science and Technology Patent Biological Deposit Center. The contents specifying the deposit will be described below.
- the above Lactobacillus gasseri OLL2716 was isolated from human feces.
- Lactobacillus gasseri OLL2959 strain is deposited at the Patent Microorganism Depositary Center for Product Evaluation Technology Foundation. The contents specifying the deposit will be described below.
- the above Lactobacillus gasseri OLL2959 strain was isolated from human feces. It is a gram-positive rod and does not produce gas from glucose. Utilizes glucose, mannose, fructose, galactose, sucrose, cellobiose.
- the method for promoting the growth and / or improving the survival of the Lactobacillus lactic acid bacterium comprises the above-mentioned ⁇ -caseinoglyco macropeptide-containing product as an active ingredient and a Lactobacillus lactic acid bacterium growth promoter and / or survival. It is performed by adding a property improver to a Lactobacillus genus lactic acid bacteria containing composition.
- the timing of the addition may be any before, during, or after fermentation of the Lactobacillus lactic acid bacteria-containing composition, but preferably contains the lactic acid bacteria because it is easy to uniformly manage the effects and actions of the entire product. It is before fermentation of the composition, and more preferably before sterilization of the lactic acid bacteria-containing composition, since the ⁇ -caseinoglyco macropeptide-containing material can be easily managed hygienically.
- the growth promoter and / or survival improver of the present invention may further be used in foods and food compositions. That is, the growth promoter and / or survival improver of the present invention can be used for foods and food compositions containing the lactic acid bacteria.
- the food and food composition include various foods and beverages (soft drinks, fermented milk, yogurt, etc.).
- a food or a food composition containing the growth promoter and / or survival improver of the present invention and the lactic acid bacterium described above can be used as it is or mixed with other foods or food ingredients. It can be used according to conventional methods in the composition. In addition, the state and form of food and drink that are usually used, such as solid (powder, granule, etc.), paste, liquid, or suspension may be used.
- ingredients are not particularly limited, but water, protein, carbohydrates, lipids, vitamins, minerals, organic acids, organic bases, fruit juices, flavors, etc. are used as ingredients in the foods and food compositions. be able to. These components can be used in combination of two or more kinds, and synthetic products and / or foods and food compositions containing many of these may be used.
- Lactobacillus gasseri OLL2716 strain (FERM BP-6999), a probiotic strain of yogurt, and Lactobacillus gasseri OLL2959 strain (NITE BP-244), a probiotic strain of the same strain, in the yogurt -The effect of caseinoglyco macropeptide (CGMP) was examined.
- CGMP caseinoglyco macropeptide
- CGMP-10 manufactured by Arraughs Ingredients Japan Co., Ltd. was used.
- yogurts were stored at 5 ° C. for 16 days as the expiration date. During the storage period, there was no difference in flavor, physical properties, lactic acid acidity, and pH depending on whether or not CGMP was added. Furthermore, at the start of storage (immediately after preparation), 8 days and 16 days later, the number of bacteria of Lactobacillus gasseri OLL2716 strain was measured. Table 1 shows the number of bacteria and the survival rate (the number of viable bacteria after the storage days / the number of viable bacteria at the start of storage (%)). Further, the survival rate of the number of bacteria of the Lactobacillus gasseri OLL2716 strain (number of viable cells after storage days / number of viable cells at the start of storage (%)) is shown in FIG.
- yogurts were stored at 5 ° C. for 16 days as the expiration date. During the storage period, there was no difference in flavor, physical properties, lactic acid acidity, and pH depending on whether or not CGMP was added. Furthermore, at the start of storage (immediately after preparation), 8 days and 16 days later, the number of bacteria of Lactobacillus gasseri OLL2959 strain was measured. Table 2 shows the number of bacteria and the survival rate (the number of viable cells after the storage days / the number of viable cells at the start of storage (%)). Further, the survival rate of the number of bacteria of the Lactobacillus gasseri OLL2959 strain (number of viable cells after storage days / number of viable cells at the start of storage (%)) is shown in FIG.
- the survival rate of Lactobacillus gasseri OLL2716 strain was 100% at the start of storage (immediately after preparation), 22.1% when CGMP was not added, and CGMP In the case of addition, it was 42.8%.
- the survival rate of Lactobacillus gasseri OLL2959 strain is 100% at the start of storage (immediately after preparation), 20.6% when CGMP is not added, and CGMP is added In this case, it was 41.9%.
- the survival rate of these lactic acid bacteria is very important in ensuring the quality of the product, and in the present invention, the element can be remarkably improved. Here, the survival improvement effect of lactic acid bacteria was confirmed.
- Lactobacillus gasseri OLL2716 strain (FERM BP-6999), a probiotic strain of yogurt, was used to examine the effect of ⁇ -caseinoglyco macropeptide (CGMP) on growth promotion.
- CGMP ⁇ -caseinoglyco macropeptide
- ⁇ -caseinoglyco macropeptide-containing material By using the ⁇ -caseinoglyco macropeptide-containing material according to the present invention, there is no influence on the flavor and physical properties of the food composition, and the effect is highly durable and excellent. Alternatively, a survival improver can be provided.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Dairy Products (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Seasonings (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011529889A JP5964588B2 (ja) | 2009-09-02 | 2010-08-27 | ラクトバチルス属乳酸菌の増殖促進剤及び/又は生残性向上剤 |
SG2012015327A SG178985A1 (en) | 2009-09-02 | 2010-08-27 | Proliferation-enhancing agent and/or survivability-improving agent for lactic acid bacterium belonging to genus lactobacillus |
HK13100393.8A HK1173182B (en) | 2009-09-02 | 2010-08-27 | Proliferation-enhancing agent and/or survivability-improving agent for lactic acid bacterium belonging to genus lactobacillus |
IN2283DEN2012 IN2012DN02283A (cs) | 2009-09-02 | 2010-08-27 | |
CN201080039225.8A CN102575223B (zh) | 2009-09-02 | 2010-08-27 | 乳杆菌属乳酸菌的增殖促进剂和/或存活性提高剂 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009203157 | 2009-09-02 | ||
JP2009-203157 | 2009-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011027719A1 true WO2011027719A1 (ja) | 2011-03-10 |
Family
ID=43649257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2010/064569 WO2011027719A1 (ja) | 2009-09-02 | 2010-08-27 | ラクトバチルス属乳酸菌の増殖促進剤及び/又は生残性向上剤 |
Country Status (5)
Country | Link |
---|---|
JP (2) | JP5964588B2 (cs) |
CN (1) | CN102575223B (cs) |
IN (1) | IN2012DN02283A (cs) |
SG (1) | SG178985A1 (cs) |
WO (1) | WO2011027719A1 (cs) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013136768A1 (ja) * | 2012-03-13 | 2013-09-19 | 株式会社明治 | コラーゲンを配合した発酵乳及びその製造方法 |
JP2013192470A (ja) * | 2012-03-16 | 2013-09-30 | Snow Brand Milk Products Co Ltd | 生存率が高い乳酸菌を含む飲食品および該飲食品の製造方法 |
JP2015050993A (ja) * | 2013-08-07 | 2015-03-19 | 国立大学法人 岡山大学 | 消化管内および糞便由来乳酸菌培養用乳もしくは豆乳由来組成物、培養用又は発酵用原料及び乳酸発酵物 |
JP2018201405A (ja) * | 2017-06-05 | 2018-12-27 | 雪印メグミルク株式会社 | 乳酸菌の生残性向上及び/又は増殖促進用組成物 |
WO2021246392A1 (ja) | 2020-06-02 | 2021-12-09 | アサヒグループホールディングス株式会社 | 乳酸菌増殖促進剤 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6495869B2 (ja) * | 2016-07-15 | 2019-04-03 | 日清食品ホールディングス株式会社 | ヒアルロン酸産生促進能を有する乳酸菌 |
CN106858261A (zh) * | 2017-05-03 | 2017-06-20 | 黑龙江众生生物工程有限公司 | 一种用于果蔬汁发酵的乳酸菌发酵促进剂及其应用 |
CN107668208A (zh) * | 2017-11-13 | 2018-02-09 | 海普诺凯营养品有限公司 | 一种促进肠道健康的配方奶粉 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05207846A (ja) * | 1992-01-29 | 1993-08-20 | Snow Brand Milk Prod Co Ltd | 乳酸菌が腸管に定着しやすい発酵乳及び乳酸菌飲料 |
JP2006501281A (ja) * | 2002-09-26 | 2006-01-12 | プロバイオヘルス・エルエルシー | 油乳化プロバイオティックカプセル封入物のプレバイオティックおよび保存的使用 |
WO2009069498A1 (ja) * | 2007-11-27 | 2009-06-04 | Meiji Dairies Corporation | 乳酸菌の生残性向上剤及び生残性向上方法、並びに食品組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3106256B2 (ja) * | 1991-08-07 | 2000-11-06 | 雪印乳業株式会社 | κ−カゼイングリコマクロペプチドの製造法 |
JP3291250B2 (ja) * | 1998-07-15 | 2002-06-10 | 農畜産業振興事業団 | ホエー飲料とその製造法 |
JP4283276B2 (ja) * | 2004-05-19 | 2009-06-24 | 森永乳業株式会社 | 発酵乳 |
JP5237581B2 (ja) * | 2006-05-31 | 2013-07-17 | 株式会社明治 | 血中尿酸値低減作用を有する乳酸菌 |
WO2009069219A1 (ja) * | 2007-11-29 | 2009-06-04 | Meiji Dairies Corporation | 血中尿酸値低減作用を有する乳酸菌 |
-
2010
- 2010-08-27 SG SG2012015327A patent/SG178985A1/en unknown
- 2010-08-27 JP JP2011529889A patent/JP5964588B2/ja active Active
- 2010-08-27 WO PCT/JP2010/064569 patent/WO2011027719A1/ja active Application Filing
- 2010-08-27 IN IN2283DEN2012 patent/IN2012DN02283A/en unknown
- 2010-08-27 CN CN201080039225.8A patent/CN102575223B/zh active Active
-
2016
- 2016-04-28 JP JP2016091253A patent/JP6193439B2/ja active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05207846A (ja) * | 1992-01-29 | 1993-08-20 | Snow Brand Milk Prod Co Ltd | 乳酸菌が腸管に定着しやすい発酵乳及び乳酸菌飲料 |
JP2006501281A (ja) * | 2002-09-26 | 2006-01-12 | プロバイオヘルス・エルエルシー | 油乳化プロバイオティックカプセル封入物のプレバイオティックおよび保存的使用 |
WO2009069498A1 (ja) * | 2007-11-27 | 2009-06-04 | Meiji Dairies Corporation | 乳酸菌の生残性向上剤及び生残性向上方法、並びに食品組成物 |
Non-Patent Citations (1)
Title |
---|
MASAHARU SAKASHITA: "CGMP, a Milk Derived Physiological Peptide", FOOD PROCESSING AND INGREDIENTS, vol. 34, no. 8, 1999, pages 44 - 46 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013136768A1 (ja) * | 2012-03-13 | 2013-09-19 | 株式会社明治 | コラーゲンを配合した発酵乳及びその製造方法 |
CN104202988A (zh) * | 2012-03-13 | 2014-12-10 | 株式会社明治 | 配合有胶原的发酵乳及其制造方法 |
JPWO2013136768A1 (ja) * | 2012-03-13 | 2015-08-03 | 株式会社明治 | コラーゲンを配合した発酵乳及びその製造方法 |
CN104202988B (zh) * | 2012-03-13 | 2017-02-22 | 株式会社明治 | 配合有胶原的发酵乳及其制造方法 |
JP2013192470A (ja) * | 2012-03-16 | 2013-09-30 | Snow Brand Milk Products Co Ltd | 生存率が高い乳酸菌を含む飲食品および該飲食品の製造方法 |
JP2015050993A (ja) * | 2013-08-07 | 2015-03-19 | 国立大学法人 岡山大学 | 消化管内および糞便由来乳酸菌培養用乳もしくは豆乳由来組成物、培養用又は発酵用原料及び乳酸発酵物 |
JP2018201405A (ja) * | 2017-06-05 | 2018-12-27 | 雪印メグミルク株式会社 | 乳酸菌の生残性向上及び/又は増殖促進用組成物 |
JP2022009842A (ja) * | 2017-06-05 | 2022-01-14 | 雪印メグミルク株式会社 | 乳酸菌の生残性向上及び/又は増殖促進用組成物 |
WO2021246392A1 (ja) | 2020-06-02 | 2021-12-09 | アサヒグループホールディングス株式会社 | 乳酸菌増殖促進剤 |
JPWO2021246392A1 (cs) * | 2020-06-02 | 2021-12-09 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2011027719A1 (ja) | 2013-02-04 |
CN102575223B (zh) | 2015-03-25 |
JP5964588B2 (ja) | 2016-08-03 |
HK1173182A1 (en) | 2013-05-10 |
JP2016135151A (ja) | 2016-07-28 |
CN102575223A (zh) | 2012-07-11 |
IN2012DN02283A (cs) | 2015-08-21 |
SG178985A1 (en) | 2012-04-27 |
JP6193439B2 (ja) | 2017-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6193439B2 (ja) | ラクトバチルス属乳酸菌の増殖促進剤及び/又は生残性向上剤 | |
JP6088821B2 (ja) | 乳酸菌および/またはビフィズス菌の生残性向上剤 | |
KR20100087078A (ko) | 유산균의 생잔성 향상제 및 생잔성 향상 방법, 및 식품 조성물 | |
JP4802216B2 (ja) | ビフィドバクテリウム属菌含有組成物及びビフィドバクテリウム属菌含有組成物の製造方法 | |
KR20150138846A (ko) | 두유 발효물 | |
Koutinas | Fermented dairy products | |
Basavanna et al. | Evaluation of functional aspects of Lactobacillus fermentum CFR 2195 isolated from breast fed healthy infants’ fecal matter | |
Li et al. | Identification of potential probiotic Lactobacillus plantarum isolates with broad-spectrum antibacterialactivity | |
JP6018771B2 (ja) | 還元型グルタチオン高含有乳酸菌発酵物およびその製造方法 | |
Alhaj et al. | Milk‐derived bioactive components from fermentation | |
EP2647294A1 (en) | Method for producing fermented food containing bifidobacterium bacteria | |
Maity et al. | Development of healthy whey drink with Lactobacillus rhamnosus, Bifidobacterium bifidum and Propionibacterium freudenreichii subsp. shermanii | |
Setiarto et al. | Nutritional and microbiological characteristics of Dadih and their application to the food industry: A review | |
Manhar et al. | Assessment of goat milk-derived potential probiotic L. lactis AMD17 and its application for preparation of dahi using honey | |
WO2009150888A1 (ja) | 乳タンパク質分解物、乳タンパク質分解物の製造方法及びビフィズス菌増殖促進剤 | |
JP6262412B1 (ja) | 発酵乳の製造における発酵時間の短縮方法、及び発酵乳における酸味の上昇の抑制方法 | |
JP4023791B2 (ja) | 抗菌物質産生乳酸菌およびそれを用いた機能性食品 | |
JP2015050993A (ja) | 消化管内および糞便由来乳酸菌培養用乳もしくは豆乳由来組成物、培養用又は発酵用原料及び乳酸発酵物 | |
Worku et al. | The Role of Starter Culture in Producing Probiotic Yoghurt: Significance for Human Health—A Review | |
JP2006014654A (ja) | 抗体含有食品 | |
Khachatryan et al. | A STUDY OF LACTIC ACID BACTERIA AND PROSPECTS FOR THEIR APPLICATION. | |
JP6966275B2 (ja) | 乳酸菌の生残性向上方法 | |
JP4051353B2 (ja) | 腸内生息性乳酸菌を高濃度で含有する乳酸醗酵食品およびその製造方法 | |
HK1173182B (en) | Proliferation-enhancing agent and/or survivability-improving agent for lactic acid bacterium belonging to genus lactobacillus | |
Soni | Physicochemical and microbial profiling of kefir from cow and buffalo milk: implications for probiotic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080039225.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10813668 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011529889 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1201000920 Country of ref document: TH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2283/DELNP/2012 Country of ref document: IN |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10813668 Country of ref document: EP Kind code of ref document: A1 |